Similar Search Results

Special issue: Pharmaceutical economics : essays in honor of Henry G. Grabowski

Mullins, C. Daniel (contributor); … - 2011

Persistent link: https://www.econbiz.de/10009298488

Most-favored-customer protection and medicaid rebates under OBRA 1990 : a challenge for the profession

Mullins, C. Daniel - In: Journal of research in pharmaceutical economics 7 (1996) 3, pp. 49-63

Persistent link: https://www.econbiz.de/10001204587

The impact of pipeline drugs on drug spending growth

Mullins, C. Daniel (contributor) - In: Health affairs : at the intersection of health, health … 20 (2001) 5, pp. 210-215

Persistent link: https://www.econbiz.de/10001608862

Pharmaceutical market impact of the early 1990's health care debate

Mullins, C. Daniel; Lyons, Bridget M.; Ahn, Jeonghoon - In: Journal of research in pharmaceutical economics 11 (2001) 2, pp. 1-22

Persistent link: https://www.econbiz.de/10001651692

How do US health care payers react to and use pharmacoeconomic information?

Mullins, C. Daniel; Ratner, Jonathan; Ball, Daniel E. - In: International journal of the economics of business 18 (2011) 2, pp. 317-330

Persistent link: https://www.econbiz.de/10009298447

Comparisons of changes over time in per capita health expenditures across racial and ethnic groups

Wang, Junling; Mullins, C. Daniel; Chang, Cyril F.; … - In: International Journal of Public Policy 6 (2010) 3/4, pp. 172-189

The study compared changes over time in health expenditures across race and ethnicity, using data from the Medical Expenditure Panel Survey. Changes from 1996-1997 to 2004-2005 were compared between non-Hispanic Whites (NHW) and non-Hispanic Blacks (NHB) and between NHW and Hispanic Whites (HW)....

Persistent link: https://www.econbiz.de/10010670278